GEMP News

Four IPOs raised almost $700 million this past week. Coming in first was First Hawaiian with an 8% gain; the state's largest bank raised $485 million in the largest banking IPO since 2014. Meanwhile, high-growth retailer At Home Group was not a home run, trading up just 2%. While new IPO filings have yet to pick up, market conditions appear ripe for sustained deal flow after...read more

Gemphire Therapeutics, which is developing a novel nonstatin therapy to treat high cholesterol, raised $30 million by offering 3 million shares at $10, below the range of $11 to $13. Gemphire Therapeutics plans to list on the Nasdaq under the symbol GEMP. Jefferies and RBC Capital Markets acted as lead managers on the deal....read more

Gemphire Therapeutics, which is developing a novel nonstatin therapy to treat high cholesterol, lowered the proposed deal size for its upcoming IPO on Thursday. The Northville, MI-based company now plans to raise $30 million by offering 3.0 million shares at a price of $10. The company had previously filed to offer 3.75 million shares at a range of $11 to $13. At the midpoint...read more

Four IPOs are on the calendar to raise nearly $900 million in the week ahead. Three are profitable, including the fourth-largest offering of 2016 and two companies that grew more than 30% in the MRQ. A biotech with heavy insider buying will also come to market, another IPO in the most...read more